10:17 EDT Summit Therapeutics (SMMT) in talks for $15B AstraZeneca (AZN) partnership, Bloomberg says
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- Strategic Collaboration and Growth Potential Drive Positive Outlook for Summit Therapeutics
- Summit Therapeutics initiated with a Buy at UBS
- Revolution Medicines, Summit Therapeutics enter clinical collaboration
- Revolution Medicines, Summit Therapeutics team to evaluate RAS inhibitors
- Summit Therapeutics’ Promising Clinical Trials and Market Potential Drive Buy Rating